Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds Read more
Roche announces positive results for first global phase III study investigating one-dose Xofluza (baloxavir marboxil) in children with flu Read more
GSK announces phase III start for its anti GM-CSF antibody, otilimab, in patients with rheumatoid arthritis (RA) Read more
Appili Signs $3M USD Grant Contract with the United States Department of Defense to Develop Antibiotics that Target Superbugs Read more